ALMS

Alumis Inc.

9.17 USD

Last updated Sep 12, 01:51 UTC

Yesterday HIGH

$10.55

Yesterday LOW

$9.65

52w HIGH

$31.35

52w LOW

$3.76

EPS

-1.11

PE

-8.26

Next Earnings

Nov 12, 2026

Overview News Unusual Options Flow Government Trades Fundamentals

Alumis Inc. stock is down -62.43% since 30 days ago. The next earnings date is Nov 12, 2026. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 September’s closed higher than August. In the last 10 Unusual Options Trades, there were 5 PUTs, 5 CALLs. 67% of analysts rate it a buy.

Options Flow Last 10
Date & Time	Expiration Date	Strike Price	Trade Type	Size	Open Interest

01 Sep 16:36	18 Sep, 2026	25.00	PUT	20	3002
01 Sep 17:16	16 Oct, 2026	12.00	PUT	200	225
01 Sep 18:29	15 Jan, 2027	13.00	CALL	2000	0
02 Sep 16:52	16 Oct, 2026	12.00	PUT	191	373
02 Sep 16:53	16 Oct, 2026	23.00	PUT	26	28
03 Sep 13:53	18 Sep, 2026	20.00	PUT	550	4988
03 Sep 14:37	16 Apr, 2027	5.00	CALL	40	5
03 Sep 16:55	18 Dec, 2026	15.00	CALL	800	31
03 Sep 16:56	18 Dec, 2026	15.00	CALL	3200	31
08 Sep 15:01	18 Dec, 2026	15.00	CALL	700	4095

Advanced Data Unlock

Vandana Singh

Tue Aug 11, 2026

Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates

Alumis releases long-term data for psoriasis drug envudeucitinib, boasting top skin clearance rates ahead of a Q4 FDA filing with FDA.
Benzinga Newsdesk

Mon Aug 10, 2026

Alumis Reports Topline Results From Ongoing ONWARD3 Long-Term Extension Study Showing 54% Of Patients Reached Complete Skin Clearance After 48 Weeks Of Continuous Envudeucitinib Treatment

– Favorable long-term safety and tolerability profile remained consistent with previously reported data –– On track to submit a New Drug Application to FDA in 4Q 2026 –SOUTH SAN FRANCISCO, Calif., Aug. 10, 2026 (GLOBE
Benzinga Newsdesk

Mon Aug 3, 2026

HC Wainwright & Co. Reiterates Neutral on Alumis, Maintains $25 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Alumis (NASDAQ:ALMS) with a Neutral and maintains $25 price target.
Benzinga Newsdesk

Tue May 19, 2026

Chardan Capital Maintains Buy on Alumis, Raises Price Target to $40

Chardan Capital analyst Janani Sundararajan maintains Alumis (NASDAQ:ALMS) with a Buy and raises the price target from $38 to $40.
Avi Kapoor

Fri May 15, 2026

This Unity Bancorp Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

Top Wall Street analysts changed outlook on top names. DA Davidson initiated coverage on EBC & UNTY with Buy ratings. See other analyst views.
Benzinga Newsdesk

Fri May 15, 2026

Wells Fargo Maintains Overweight on Alumis, Raises Price Target to $51

Wells Fargo analyst Derek Archila maintains Alumis (NASDAQ:ALMS) with a Overweight and raises the price target from $49 to $51.
Benzinga Newsdesk

Fri May 15, 2026

Guggenheim Maintains Buy on Alumis, Raises Price Target to $34

Guggenheim analyst Yatin Suneja maintains Alumis (NASDAQ:ALMS) with a Buy and raises the price target from $32 to $34.
Avi Kapoor

Fri May 15, 2026

This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top analysts changed outlook on top names. See all rating changes on analyst ratings page. Check out analysts' views on ALMS stock.
Benzinga Newsdesk

Fri May 15, 2026

HC Wainwright & Co. Downgrades Alumis to Neutral, Maintains Price Target to $25

HC Wainwright & Co. analyst Mitchell S. Kapoor downgrades Alumis (NASDAQ:ALMS) from Buy to Neutral and maintains the price target from $25 to $25.
Benzinga Newsdesk

Thu May 14, 2026

Alumis Q1 EPS $(0.74) Beats $(0.77) Estimate, Sales $1.741M Miss $2.767M Estimate

Alumis (NASDAQ:ALMS) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.77) by 3.9 percent. This is a 59.34 percent increase over losses of $(1.82) per share from the same

Guggenheim

Thu Sep 3, 15:34

hold

downgrade
Oppenheimer

Wed Sep 2, 18:50

buy

confirm
Wells Fargo

Wed Sep 2, 16:28

buy

confirm
Morgan Stanley

Wed Sep 2, 14:19

buy

confirm
HC Wainwright & Co.

Wed Sep 2, 13:18

buy

upgrade
HC Wainwright & Co.

Fri Aug 14, 19:25

hold

confirm